HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up

Published:2017-07-29 Issue:12 Volume:24 Page:1107-1113
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Stelma F.¹,van der Ree M. H.¹^ORCID,Jansen L.¹,Peters M. W.¹,Janssen H. L. A.²³,Zaaijer H. L.⁴,Takkenberg R. Bart¹,Reesink H. W.¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology; Academic Medical Center; Amsterdam The Netherlands

2. Department of Gastroenterology and Hepatology; Erasmus Medical Center; Rotterdam The Netherlands

3. Toronto Centre for Liver Disease; Toronto Western & General Hospital; University Health Network; Toronto ON Canada

4. Department of Clinical Virology; Academic Medical Center; Amsterdam The Netherlands

Funder

AbbVie

Arbutus

Benitec

Bristol-Myers Squibb

Gilead Sciences

Innogenetics

Janssen Pharmaceuticals

MedImmune

Medtronic

Merck

Roche

Abbott Fund

Grifols

Janssen-Cilag

Boehringer Ingelheim

ENYO

PRA Health Sciences

Regulus

R-Pharm

Replicor

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12738/fullpdf

Reference27 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

3. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

4. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA;Lucifora;Science (80-),2014

5. Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes;Liu;PLoS Pathog,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients;Journal of Clinical and Experimental Hepatology;2022-05

2. Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record;Genes & Diseases;2022-03

3. Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg);Journal of Clinical Medicine;2022-02-21

4. Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B;Hepatology;2022-02-14

5. Chronic hepatitis B: New potential therapeutic drugs target;World Journal of Virology;2022-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3